NCT03570268
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Basal Ganglia Diseases, +16 more
- Locations
-
- Fondazione Don Gnocchi ONLUS Milan, Italy
Clinical trial condition
Multiple Sclerosis
Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.
2,361 public trials
354 recruiting studies
Multiple Sclerosis trial results
NCT01381354
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +9 more
- Locations
-
- Univeristy of Iowa/ VA Iowa City VA Medical Center Iowa City, Iowa, United States
NCT01915433
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
- Locations
-
- Univeristy of Iowa Iowa City, Iowa, United States
- Univeristy of Iowa Iowa City, Iowa, United States
Completed
Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b
NCT03408093
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
Not specified
NCT03561155
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- UOC Neurorehabilitation Verona, Italy
NCT02846558
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Body Weight, +9 more
- Locations
-
Not specified
NCT03187847
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +9 more
- Locations
-
- Kliniken Valens Valens, Switzerland
NCT01569451
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
NCT03548974
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +12 more
- Locations
-
Not specified
Completed
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis
NCT01457924
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- GSK Investigational Site Cullman, Alabama, United States
- GSK Investigational Site Fullerton, California, United States
- GSK Investigational Site Fairfield, Connecticut, United States
- GSK Investigational Site Miami, Florida, United States